Abstract
(S)-N-[1-(4-Cyclopropylmethyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-ethyl]-3-(2-fluoro-phenyl)-acrylamide ((S)-2) was identified as a potent and efficacious KCNQ2 opener. This compound demonstrated significant activity in reducing neuronal hyperexcitability in rat hippocampal slices, and the inhibition mediated by (S)-2 was reversed by the KCNQ blocker linopirdine.
MeSH terms
-
Acrylamides / chemical synthesis
-
Acrylamides / pharmacology*
-
Animals
-
Dose-Response Relationship, Drug
-
Hippocampus / drug effects*
-
Hippocampus / metabolism
-
Hippocampus / pathology
-
Humans
-
KCNQ2 Potassium Channel
-
Kidney / cytology
-
Kidney / drug effects
-
Kidney / metabolism
-
Mice
-
Molecular Structure
-
Neurons / drug effects*
-
Neurons / metabolism
-
Neurons / pathology
-
Oxazines / chemical synthesis
-
Oxazines / pharmacology*
-
Patch-Clamp Techniques
-
Potassium Channels / drug effects*
-
Potassium Channels / genetics
-
Potassium Channels / metabolism
-
Potassium Channels, Voltage-Gated
-
Rats
-
Structure-Activity Relationship
Substances
-
Acrylamides
-
KCNQ2 Potassium Channel
-
KCNQ2 protein, human
-
Kcnq2 protein, rat
-
N-(1-(4-cyclopropylmethyl-3,4-dihydro-2H-benzo(1,4)oxazin-6-yl)ethyl)-3-(2-fluorophenyl)acrylamide
-
Oxazines
-
Potassium Channels
-
Potassium Channels, Voltage-Gated